Objective: To report an ataxic variant of Alzheimer disease expressing a novel molecular phenotype. Design: Description of a novel phenotype associated with a presenilin 1 mutation. Setting: The subject was an outpatient who was diagnosed at the local referral center. Patient: A 28-year-old man presented with psychiatric symptoms and cerebellar signs, followed by cognitive dysfunction. Severe beta-amyloid (A beta) deposition was accompanied by neurofibrillary tangles and cell loss in the cerebral cortex and by Purkinje cell dendrite loss in the cerebellum. A presenilin 1 gene (PSEN1) S170F mutation was detected. Main Outcome Measures: We analyzed the processing of A beta precursor protein in vitro as well as the A beta species in brain tissue. Results: The PSEN1 S170F mutation induced a 3-fold increase of both secreted A beta(42) and A beta(40) species and a 60% increase of secreted A precursor protein in transfected cells. Soluble and insoluble fractions isolated from brain tissue showed a prevalence of N-terminally truncated A beta species ending at both residues 40 and 42. Conclusion: These findings define a new Alzheimer disease molecular phenotype and support the concept that the phenotypic variability associated with PSEN1 mutations may be dictated by the A beta aggregates' composition.

Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype

PICCINI, ALESSANDRA;BORGHI, ROBERTA;DAMONTE, GIANLUCA;TABATON, MASSIMO
2007-01-01

Abstract

Objective: To report an ataxic variant of Alzheimer disease expressing a novel molecular phenotype. Design: Description of a novel phenotype associated with a presenilin 1 mutation. Setting: The subject was an outpatient who was diagnosed at the local referral center. Patient: A 28-year-old man presented with psychiatric symptoms and cerebellar signs, followed by cognitive dysfunction. Severe beta-amyloid (A beta) deposition was accompanied by neurofibrillary tangles and cell loss in the cerebral cortex and by Purkinje cell dendrite loss in the cerebellum. A presenilin 1 gene (PSEN1) S170F mutation was detected. Main Outcome Measures: We analyzed the processing of A beta precursor protein in vitro as well as the A beta species in brain tissue. Results: The PSEN1 S170F mutation induced a 3-fold increase of both secreted A beta(42) and A beta(40) species and a 60% increase of secreted A precursor protein in transfected cells. Soluble and insoluble fractions isolated from brain tissue showed a prevalence of N-terminally truncated A beta species ending at both residues 40 and 42. Conclusion: These findings define a new Alzheimer disease molecular phenotype and support the concept that the phenotypic variability associated with PSEN1 mutations may be dictated by the A beta aggregates' composition.
File in questo prodotto:
File Dimensione Formato  
Piccini_et_al_2007.pdf

accesso chiuso

Tipologia: Documento in versione editoriale
Dimensione 398.3 kB
Formato Adobe PDF
398.3 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11567/226708
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 47
  • ???jsp.display-item.citation.isi??? 45
social impact